quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:00:11·28d
SECFiling
XORTX Therapeutics Inc. logo

SEC Form 6-K filed by XORTX Therapeutics Inc.

XRTX· XORTX Therapeutics Inc.
Health Care
Original source

Companies

  • XRTX
    XORTX Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Dec 9UpdateAlliance Global Partners$11.00

Related

  • SEC20h
    SEC Form POS AM filed by XORTX Therapeutics Inc.
  • SEC2d
    SEC Form POS AM filed by XORTX Therapeutics Inc.
  • SEC3d
    SEC Form 6-K filed by XORTX Therapeutics Inc.
  • PR3d
    XORTX Meets Nasdaq Continued Listing Requirements
  • SEC8d
    SEC Form 6-K filed by XORTX Therapeutics Inc.
  • PR10d
    XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
  • SEC23d
    SEC Form 6-K filed by XORTX Therapeutics Inc.
  • PR23d
    XORTX Confirms Effective Date of Share Consolidation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022